The Morningside Foundation invested $10 million into Atlanta-based Emory University to promote research into groundbreaking, cost-effective treatments for cancer and other diseases.
As a result of the investment, the university will rename its recently launched Center for Affordable Medical Innovation the Morningside Center for Innovative and Affordable Medicine. The center was initially launched with an investment from the Robert W. Woodruff Foundation and is based within Emory's Woodruff Health Sciences Center.
Though research at the center will initially focus on cancer treatments, it will expand over time to develop diagnostics, devices and care delivery systems, all in the pursuit of increased affordability and access.
"The Morningside Center represents a unique initiative because of its dual focus on innovation and affordability," Jonathan Lewin, MD, Emory's executive vice president for health affairs and president, chair and CEO of Emory Healthcare, said in a statement. "In addition to its focus on research, the center's emphasis on education and advocacy for effective and affordable medical treatment will provide learning opportunities for health care professionals at all levels."
More articles on innovation:
U of South Florida, Microsoft unveil 1st Medical School of Innovation
Shriners Hospitals launches genomics institute for precision medicine
U of Michigan $300M research center to anchor 14-acre Detroit innovation hub